Position in ABBV
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$1,846,785
+$261,718 QoQ
Shares Held
7,339
+0.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.31%
of 13F equity value
Holder Rank
#2,025
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LifeSteps Financial, Inc. holds $4,238,352 across 14 Drug Manufacturers - General names. ABBV ranks #1 (43.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
7,339 | $1,846,785 | |
| 2 | JNJ |
Johnson & Johnson
|
4,127 | $1,048,134 | |
| 3 | NVO |
Novo Nordisk A S
|
7,446 | $356,961 | |
| 4 | LLY |
ELI LILLY & Co
|
263 | $315,450 | |
| 5 | AMGN |
Amgen Inc
|
813 | $294,403 | |
| 6 | PFE |
Pfizer Inc
|
5,307 | $127,792 | |
| 7 | MRK |
Merck & Co., Inc.
|
805 | $103,442 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,484 | $85,508 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,846,785 | 7,339 | Shares | Sole | 2026-07-17 | |
| 2026-03-31 | $1,585,067 | 7,288 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $1,674,603 | 7,329 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,693,946 | 7,316 | Shares | Sole | 2025-10-16 | |
| 2025-06-30 | $1,365,791 | 7,358 | Shares | Sole | 2025-07-23 | |
| 2025-03-31 | $1,530,334 | 7,304 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $1,285,304 | 7,233 | Shares | Sole | 2025-02-03 | |
| 2024-09-30 | $1,465,104 | 7,419 | Shares | Sole | 2024-10-16 | |
| 2024-06-30 | $1,256,212 | 7,324 | Shares | Sole | 2024-07-17 | |
| 2024-03-31 | $1,341,166 | 7,365 | Shares | Sole | 2024-04-26 | |
| 2023-12-31 | $1,150,497 | 7,424 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $1,104,385 | 7,409 | Shares | Sole | 2023-10-25 | |
| 2023-06-30 | $997,406 | 7,403 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $1,181,887 | 7,416 | Shares | Sole | 2023-04-12 | |
| 2022-12-31 | $1,209,166 | 7,482 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $981,880 | 7,316 | Shares | Sole | 2022-10-14 | |
| 2022-06-30 | $1,073,957 | 7,012 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $1,230,577 | 7,591 | Shares | Sole | 2022-04-12 | |
| 2021-12-31 | $999,387 | 7,381 | Shares | Sole | 2022-01-26 | |
| 2021-09-30 | $829,520 | 7,690 | Shares | Sole | 2021-10-06 | |
| 2021-06-30 | $851,333 | 7,558 | Shares | Sole | 2021-07-09 | |
| 2021-03-31 | $684,816 | 6,328 | Shares | Sole | 2021-04-20 | |
| 2020-12-31 | $514,534 | 4,802 | Shares | Sole | 2021-01-25 | |
| 2020-09-30 | $399,848 | 4,565 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $447,995 | 4,563 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $265,979 | 3,491 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||